A Study of IXAZOMIB in Adult Patients With Lymphoma
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This study is an open-label, multicenter, phase 1, dose-escalation study of IXAZOMIB in adult
patients with lymphoma. This study will be the first to administer IXAZOMIB to patients with
lymphoma.